{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:23:33Z","timestamp":1794579813019,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011494","name":"Baoding City Science and Technology and Intellectual Property Bureau","doi-asserted-by":"publisher","award":["2441ZF128"],"award-info":[{"award-number":["2441ZF128"]}],"id":[{"id":"10.13039\/501100011494","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.humimm.2026.112064","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:02:31Z","timestamp":1788537751000},"page":"112064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Graft CD3+\/CD4\u00a0\u2212\u00a0CD8\u2212 T-cell ratio: A predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients"],"prefix":"10.1016","volume":"87","author":[{"given":"Xiaoling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.humimm.2026.112064_bb0005","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"17","key":"10.1016\/j.humimm.2026.112064_bb0010","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.humimm.2026.112064_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humimm.2026.112064_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.humimm.2026.112064_bb0025","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"New England J. Med."},{"issue":"7","key":"10.1016\/j.humimm.2026.112064_bb0030","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.humimm.2026.112064_bb0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc1365","article-title":"Molecules and mechanisms of the graft-versus-leukaemia effect","volume":"4","author":"Bleakley","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.humimm.2026.112064_bb0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bmt.1702852","article-title":"Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia","volume":"27","author":"Morariu-Zamfir","year":"2001","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.humimm.2026.112064_bb0045","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.leu.2403718","article-title":"High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation","volume":"19","author":"Baron","year":"2005","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.humimm.2026.112064_bb0050","doi-asserted-by":"crossref","first-page":"27255","DOI":"10.18632\/oncotarget.8463","volume":"7","author":"Czerw","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.humimm.2026.112064_bb0055","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1080\/10428190903085944","article-title":"Optimizing the CD34+ cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation","volume":"50","author":"Mehta","year":"2009","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.humimm.2026.112064_bb0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/icb.2010.84","article-title":"Interleukin-10 limits the expansion of immunoregulatory CD4\u2212CD8\u2212 T cells in autoimmune-prone non-obese diabetic mice","volume":"88","author":"Hillhouse","year":"2010","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.humimm.2026.112064_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.20020029","article-title":"The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo","volume":"196","author":"Ford","year":"2002","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.humimm.2026.112064_bb0070","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1182\/blood-2002-01-0235","article-title":"Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells","volume":"100","author":"Young","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2026.112064_bb0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2026.112064_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.humimm.2026.112064_bb0085","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112064_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"22","key":"10.1016\/j.humimm.2026.112064_bb0095","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.2013.54.4577","article-title":"Improved survival after transplantation of more donor plasmacytoid dendritic or naive T cells from unrelated-donor marrow grafts: results from BMTCTN 0201","volume":"32","author":"Waller","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.humimm.2026.112064_bb0100","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1200\/JCO.2014.60.1203","article-title":"High graft CD8 cell dose predicts improved survival and enables better donor selection in allogeneic stem-cell transplantation with reduced-intensity conditioning","volume":"33","author":"Reshef","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.humimm.2026.112064_bb0105","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1182\/blood.V97.10.2948","article-title":"Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation","volume":"97","author":"Waller","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.humimm.2026.112064_bb0110","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00277-009-0728-4","article-title":"High CD4\/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched\/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia","volume":"88","author":"Xu","year":"2009","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.humimm.2026.112064_bb0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2141.2005.05363.x","article-title":"Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning","volume":"128","author":"Panse","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.humimm.2026.112064_bb0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00277-005-0037-5","article-title":"Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation","volume":"85","author":"Vela-Ojeda","year":"2006","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112064_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/bmt.2011.3","article-title":"Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia","volume":"47","author":"Gaziev","year":"2012","journal-title":"Bone Marrow Transplant."},{"issue":"5426","key":"10.1016\/j.humimm.2026.112064_bb0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.humimm.2026.112064_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0268-960X(03)00009-2","article-title":"Immunobiology of acute graft-versus-host disease","volume":"17","author":"Reddy","year":"2003","journal-title":"Blood Rev."},{"issue":"9674","key":"10.1016\/j.humimm.2026.112064_bb0140","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.humimm.2026.112064_bb0145","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"New England J. Med."},{"issue":"6","key":"10.1016\/j.humimm.2026.112064_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/sji.12289","article-title":"The role of \u03b3\u03b4 T cells in haematopoietic stem cell transplantation","volume":"81","author":"Minculescu","year":"2015","journal-title":"Scand. J. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2026.112064_bb0155","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/77513","article-title":"Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.humimm.2026.112064_bb0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.171.1.134","article-title":"Inhibition of graft-versus-host disease by double-negative regulatory T cells","volume":"171","author":"Young","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.112064_bb0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbmt.2014.09.027","article-title":"Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia","volume":"21","author":"Perko","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2026.112064_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.humimm.2026.112064_bb0175","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol. Blood Marrow Transplant."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926004106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926004106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:25:40Z","timestamp":1794576340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926004106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0198885926004106"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112064","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Graft CD3+\/CD4\u00a0\u2212\u00a0CD8\u2212 T-cell ratio: A predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112064"}}